万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://acsjournals.onlinelibrary.wiley.com/journal/10970142
3、投稿网址：http://mc.manuscriptcentral.com/cancer
4、官网邮箱：canceredoff@cancer.org（编辑部）
5、官网电话：(404) 327-6411
6、期刊刊期：半月刊，每月1日、15日出版。
2021年5月20日星期四
投稿须知【官网信息】
Author Guidelines
Sections
Submission
Aims and Scope
Manuscript Categories and Requirements
Preparing the Submission
Editorial Policies and Ethical Considerations
Author Licensing
Publication Process After Acceptance
Post Publication
Editorial Office Contact Details
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Authors can post their results in clinical trial registries or submit them to government regulatory agencies without the manuscript being considered previously published or an overlapping publication. Cancer will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/cancer.
Click here for more details on how to use ScholarOne Manuscripts.
For help with submissions, please contact: cancer@kwfco.com
2. AIMS AND SCOPE
Cancer is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of Cancer is to provide an interdisciplinary forum for the exchange of clinically applicable information among oncologic disciplines concerned with the etiology and course of human cancer. Cancer accomplishes this objective by publishing original articles, as well as other scientific and educational documents, that support the mission of the American Cancer Society by facilitating the transfer of knowledge from the laboratory to the bedside; contributing to cancer prevention, early detection, diagnosis, cure, and rehabilitation; and diminishing suffering from cancer.
AMERICAN CANCER SOCIETY MISSION
The American Cancer Society is the nationwide community based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer through research, education, advocacy, and service.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Initial submissions that exceed the length limitations as described in this guide by more than 500 words will not be considered for review.
Original Articles: Scientific reports of the results of original clinical research. The text is limited to 5000 words including the title page(s), structured abstract, text, references, and tables. Abstracts are limited to 250 words.
Review Articles: A timely, in-depth treatment of an issue. Review articles are generally solicited by the editors, but unsolicited materials will be considered. The text is limited to 6000 words including title page(s), abstract, text, references, and tables.
Editorials: Opinions of recognized leaders in oncologic specialties. Editorials are generally solicited by the Editor-in-Chief and are related to a manuscript in the same issue. Length should not exceed 2400 words with no more than 20 references.
Commentaries: Present a point of view of general interest not related to an article in the same issue of Cancer. The text is limited to 6000 words including the title page(s), text, references, and tables. Figures are encouraged. Commentaries do not include an abstract.
Communications: Brief notes on selected topics from organizations such as the American Cancer Society, the Commission on Cancer of the American College of Surgeons, and the American Joint Committee on Cancer.
Letters to the Editor: Related to papers previously published in Cancer. Letters must be submitted within three months of the online publication date of the article discussed in order to be considered. The authors of the original publication will be given the opportunity to respond in the same issue of Cancer. Letters and responses must not exceed 750 words in length and should not have tables or figures. Financial associations or other potential conflicts of interest must be disclosed.
In Memoriam: Memorialization of recently deceased individuals who have made notable contributions to the field of oncology.
Insight from the Experts: Invited piece offering research, approaches, and perspectives that provide our readers with honest, earned wisdom and guidance from established experts in oncology specialties. Length is around 1,000 words with no more than 20 references.
Cancer Case Conundrums: Invited piece presenting unusual cases and questions without an obvious solution. Length is around 1,000 words with no more than 20 references.
4. PREPARING THE SUBMISSION
Cover Letters
Provide a cover letter that describes the significance and novelty of the work, includes a statement verifying the originality of the work, and discloses any previous abstracts, presentations, reports, or publications that contain material that might be perceived to overlap with the current submission, as well as any additional information that may impact the review process. Cover letters should be addressed to Dr. Fadlo R. Khuri, the Editor-in-Chief.
Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures; supporting information (if applicable).
Main Text File
The text file should be presented in the following order:
A short informative title containing the major key words. The title should not contain abbreviations (see Wiley’s best practice SEO tips);
A short running title of less than 40 characters (not required for Letters to the Editor);
The full names (complete with middle names or initials and academic degrees) of the authors;
The authors’ institutional affiliations where the work was conducted, with a footnote for the authors’ present address if different from where the work was conducted;
Corresponding author’s complete contact information to include address, phone number, and email address;
A funding statement that includes details of all funding sources for the work in question;
A conflict of interest statement that includes details of potential conflicts for all authors (or indicates that there are none);
Author contributions statement (required for Original Articles only);
Acknowledgments;
Lay summary (optional plain language overview of the article and its key findings; limited to 100 words)
Precis for use in the Table of Contents: two concise sentences that state the significant conclusion(s) or message of the manuscript;
Abstract and keywords;
Total number of each: 1) text pages (including title page(s), abstract, main text, references, and figure legends); 2) tables; 3) figures; 4) and supporting files for publication;
Main text;
References;
Tables (each table complete with title and footnotes); tables may also be included separately as .DOC, .DOCX, .RTF, or .XLSX files;
Figure legends;
Figures and supporting information should be supplied as separate files.
Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the “Conflict of Interest” section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement, which must be included on the title page of the manuscript in addition to being entered in ScholarOne Manuscripts. To ensure that the editors and reviewers assigned have access to this information, manuscripts will not enter the peer review process unless this statement is included in the Word document.
Abstract
Original and Review Articles must contain an abstract of approximately 250 words. Structured abstracts are required for Original Articles and must have four specified subtitles: Background, Methods, Results, and Conclusion(s). Abstracts are not required for Editorials, Commentaries, Communications, or Letters to the Editor. Abstracts published in Cancer are submitted to the International Cancer Research Data Bank (ICRDB), supported by the National Cancer Institute. This facilitates broad circulation of cancer-related abstracts. If the ICRDB edits an abstract significantly, it is indicated by a notation ‘‘modified.’’ Authors are hereby made aware of this procedure in advance of submitting a manuscript to Cancer.
Keywords
Please provide 3-7 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.
Lay Summaries
Cancer is pleased to offer interested authors the opportunity to publish a lay summary with their article. A lay summary is a plain language overview of the article and its key findings that is intended to make the research findings presented in the article accessible to those outside the scientific community. Lay summaries are limited to 100 words and should be included on the title page. For tips on writing a lay summary, visit https://www.wiley.com/network/societyleaders/research-impact/how-to-write-a-lay-summary-for-your-research.
Main Text
The main document, including title page(s), manuscript, references, tables, and figure legends.
Submit text files only as .DOC, .DOCX, or .RTF file formats. Other file formats are not permitted and should be converted to .DOC or .DOCX.
Include page numbers on the document, beginning with the title page as number 1.
Please use standard 10- or 12-point font size. Manuscript should be double spaced.
References
Submit references per the following instructions:
List references double-spaced in a separate reference section immediately following the text.
Verify all references prior to submission.
Use the AMA Manual of Style, 11th ed.1 for reference format style and List of Serials Indexed for Online Users11 for standard journal abbreviations.
Number references sequentially in the order cited in the text; do not alphabetize. Remove automatic numbering and linked citations; number references manually.
Do not cite personal communications, unpublished observations, and submitted manuscripts. Reference to a paper accepted but not yet published can be listed as ‘‘in press.’’ ‘‘In press’’ references must be updated by the authors as soon as publication data are available.
Provide names of all authors in a reference when there are six or fewer; if there are seven or more authors, list only the first three, followed by ‘‘et al.’’
Authors are responsible for the accuracy and completeness of their references and for correct text citation.
Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnotes are denoted by lowercase letters in alphabetical order. Statistical measures such as SD or SEM should be identified in the headings.
Submit single-spaced on separate pages in the word processing program used. Tables imported into the word-processing program from spreadsheet programs (eg, Microsoft Excel) should be left in table format and not converted to text. Gridlines should be retained.
Limit tables to those that adequately and concisely present findings without redundancy.
Cite all tables in the text. Number tables consecutively, using Arabic numerals, in the order cited in the text. The table number is followed by a brief descriptive title.
Include table number, ‘‘continued,’’ and table subheadings on each page if a table exceeds one manuscript page.
Obtain written permission to reproduce previously published tabular material. Credits for the reproduced work are included as a footnote to the table and must include author(s), title, either publisher and city (and country, if other than US) or periodical name, volume, page, and year. Signed permission forms must be sent to the Cancer Editorial Office upon submission.
Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Figures
Submit only publication quality figures in TIFF, EPS, PPT, PPTX, or PDF file format. JPG, PNG, GIF, and DOC files are not permitted.
Figures must be clear and legible in the ScholarOne-generated PDF proof.
TIFF files should have a minimum resolution of 1200 dpi for line art, 300 dpi for halftones/color (RGB), or 600 dpi for combination halftones/line art. However, for best results, we recommend using TIFF only for photos and EPS for any image that includes graphs or text.
PPT and PPTX files should only be used for figures created in Microsoft PowerPoint.
Figures should be sized to one-column width (19 picas, 3.25 inches), or two-column width (40 picas, 6.75 inches), as appropriate.
Call out all figures in the text. Number all figures sequentially with Arabic numerals in the order cited in the text.
Provide double-spaced legends on a separate page to include the figure number and a brief description of the figure.
For typeface within figures, use 6-pt to 12-pt Arial or Helvetica font.
Figures with multiple parts should be labeled and referred to as (a), (b), (c), etc.
Obtain written permission to reproduce previously published figures. Credits for the reproduced work are included in the figure legend and must include author(s), title, either publisher and city (and country, if other than US) or periodical name, volume, page, and year. Signed permission forms must be sent to the Cancer Editorial Office upon submission.
Do not embed figures in word processing programs (eg, Microsoft Word).
Cancer reserves the right to resize and/or crop photographs to fit the journal’s format where appropriate.
Color figures are published in print and online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white. Gray shading in figures may not reproduce well for publication and should be avoided. Do not use overall background shading in figures. Do not use gray-shaded bars in graphs—use bars with solid, open, or hatched fill. Avoid fine lines and very small type and symbols in figures. Lines should be reasonably dark and type and symbols should be easily read if the figure is reduced for publication.
Image Integrity
Changes to images can create misleading results when research data are collected as images. It may, however, be legitimate and even necessary to edit images. We ask authors to declare where manipulations have been made.
Specific features within an image should not be enhanced, obscured, removed, moved, or introduced.
Original unprocessed images must be provided by authors should any indication of enhancement be identified.
Adjustments to brightness or contrast are only acceptable if they apply equally across the entire image and are applied equally to controls, and as long as they do not obscure, eliminate, or misrepresent any information present in the information originally captured.
Excessive manipulations, such as processing to emphasize one region in the image at the expense of others, are inappropriate, as is emphasizing experimental data relative to the control.
Nonlinear adjustments or deleting portions of a recording must be disclosed in a figure legend.
Constructing figures from different gels, fields, exposures, and experimental series is discouraged. When this is necessary, the component parts of composite images should be indicated by dividing lines clearly demarcated in the figure and described in the legend.
Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html
Supporting Information
Supporting information is information that is not essential to the article but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.
Click here for Wiley’s FAQs on supporting information.
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
General Style Points
The following points provide general advice on formatting and style.
Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
Matters of spelling, capitalization, punctuation, hyphenation, reference format, and general style: AMA Manual of Style, 11th ed.
Citing cancer stages: American Joint Committee on Cancer Staging Manual, 8th ed. or UICC TNM Classification of Malignant Tumors
Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
Resource Identification Initiative
The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.
Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention and in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.
Additionally, authors must include the RRIDs in the list of keywords associated with the manuscript.
To Obtain Research Resource Identifiers (RRIDs):
1) Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
2) Search for the research resource (please see the section titled “Search Features and Tips” for more information).
3) Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.
If there is a resource that is not found within the Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.
If any difficulties in obtaining identifiers arise, please contact rii-help@scicrunch.org for assistance.
……
更多详情：
https://acsjournals.onlinelibrary.wiley.com/hub/journal/10970142/homepage/forauthors.html
